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Abstract
Fibrosarcomas (FS) of bone are a rare malignancy accounting for less than 5% of all primary malignant bone
neoplasms. Diagnosis and treatment approaches of this entity are complex and require a skilled and experienced
multidisciplinary team.
Authors report their experience with a case of FS of humerus showing a pathologic complete response to neo-
adjuvant chemotherapy based on adriamycin, cisplatin and ifosfamid. This approach allowed limb-sparing surgery
with an excellent functional and psychological result.
Background
Fibrosarcomas (FS) of bone represent 5% of all primary
bone sarcomas [1,2]. It occurs most frequently in the
middle age [1], and affects men and women with equal
frequency. In addition, it affects most commonly the
l o n gb o n e s .T h et u m o rm a yb ee i t h e rc e n t r a l( 6 8 % )o r
cortical (31%) [1]. Fibrosarcomas can arises as a primary
lesions, or secondary to fibrous dysplasia, to Paget’s
disease, to bone infarcts, to osteomyelitis, or to post-
irradiation of bone and giant cell tumors (GCT) [3,4].
Histologically tumors are characterized by interlacing
bundles of collagen fibers without any osteoid, or carti-
lage production [1]. Differential diagnosis includes fibro-
blastic osteosarcoma and malignant fibrous histiocytoma
(MFH) [5].
Surgery is the standard treatment for fibrosarcoma of
bone [1]. Amputation was the primary method of ther-
apy, yielding the best curative results [1]. However, by
combining advanced bone imaging techniques with sur-
gical techniques, implant development and neo-adjuvant
therapy, limb-sparing surgery can be safely performed.
T h er o l eo fs y s t e m i cc h e m o t h e r a p yi sn o te s t a b l i s h e d .
Few published reports of chemotherapy in FS of bone
have been reported. Chemotherapy regimens used are
similar to those used for osteosarcoma. Given to the
rarity and heterogeneity of published reports it is not
possible to draw conclusions about the role of neo-
adjuvant chemotherapy in improving patients outcome
and survival.
W ep r e s e n th e r ear a r ec a s eo fl o c a l l ya d v a n c e dF So f
bone experiencing complete pathologic response to
adriamycin-cisplatin-ifosfamid neo-adjuvant chemother-
apy, allowing limb sparing surgery, to illustrate the
antitumor activity of this regimen in this rare tumor.
Case presentation
A 28-year-old woman complained of pain and tumefac-
tion in the upper portion of her right arm. She did not
have fever, or trauma. Physical examination, showed a
raised mass in the proximal portion of the right arm;
with no clinical signs of neurovascular damage. There
was no local erythema or skin lesions, and no palpable
lymphadenopathy. There were pain and limitation of
abduction, internal and external rotation of the right
limb.
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normal. Radiographs revealed a diaphyseal pathologic
fracture involving the right humerus with a periosteal
reaction. Magnetic resonance imaging (MRI) of the right
arm (Figure 1) showed an eccentric mass in the diaphy-
sis of the humerus, accompanied by an overlying perios-
teal reaction. The mass extended to a height of 11 cm,
and into surrounding soft tissues. The shoulder and
elbow appeared normal. There was no skip metastasis.
A biopsy was performed. Microscopic examination
showed fascicles of spindle cells with areas of collagen
fibers, with an elevated mitotic index (Figure 2). The
microscopic aspect suggests the diagnosis of high grade
FS of bone.
A technetium-99 m labeled methylene diphosphonate
radionucl ide (Tc 99 m/HMDP) bone scan revealed an
area of increased uptake in the right proximal humerus,
without other foci of abnormal isotope uptake that cor-
responded in location to the abnormalities visualized on
MRI. Computed tomographic (CT) scanning of the
thorax performed revealed no abnormalities. Laboratory
test results were normal, left ventricular fraction ejection
(FEV) was normal and equal to 69%.
Surgical resection is the standard treatment of FS of
bone. Early studies support the use of amputation [1].
At the Memorial Sloan-Kettering Cancer Center
(MSKCC) more than 85% patients with histologically
verified primary fibrosarcoma of bone, were treated by
major amputation between 1918 and 1973. Nevertheless
low-grade periosteal FS were treated by local wide exci-
sion rather than amputation, with encouraging results
[1]. Also many studies have demonstrated a comparable
rate of disease control and survival with amputation and
Limb-salvage procedures, as long as wide resection mar-
gins are achieved, in the treatment of sarcoma of the
extremities [6,7]. Furthermore conservative surgery
improves the quality of life of patients with best func-
tional results [6,7]. All this data encourage us to believe
that a limb saving surgery should be seriously consid-
ered in the management of FS of bone.
In our case limb salvage surgery was not possible at
the time of first presentation, and consequently neo-
adjuvant chemotherapy was considered in order to
ovoid amputation, and to achieve a wide surgical
excision.
T h er o l eo fc h e m o t h e r a p yi nF So fb o n ei su n k n o w n .
Up to now, no large chemotherapy studies of FS of
bone are published; and only few case reports are
reported. There is no recommendation regarding the
optimal drug regimens, and the protocols used are
Figure 1 Sagittal T1 - weighted MR image at the time of first
presentation, reveals a huge intra- and extraosseous tumor of
the proximal humeral diaphysis.
Figure 2 HESX4 - Spindle cells with interlacing bundles of
collagen fibers without any osteoid, or cartilage production.
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and were most commonly based on Adriamycin and
cisplatin.
API regimen is an active combination in the treatment
of osteosarcoma (French Sarcoma Group FGS) [8] with
37-47% of good pathologic response but there is no data
concerning efficacy of this protocol in FS of bone.
Based on this data, we use the API combination
(adriamycin 60 mg/m
2 and cisplatin 100 mg/m
2 on day
1a n di f o s f a m i d1 . 8g / m
2/d during 5 days with Uromi
thexan (Mesna®) 1800 mg/m
2/d during 5 days) as neo-
adjuvant chemotherapy. G-CSF (filgastrim) was admini-
strated from day 7 to day 14 of each cycle.
Hematologic and non hematologic tolerance to che-
motherapy was evaluated after each cycle, and we
showed two episodes of neutropenia (grade III and I)
and 1 episode of inter-costal Zona after the second
course of chemotherapy, successfully managed with
Valaciclovir.
Our case showed excellent clinical and radiological par-
tial response (Figure 3) after 3 courses of chemotherapy.
A conservative surgery was performed after 3 cycles;
The patient received limb-salvage procedures with wide
local resection of the tumor, reconstruction with hum-
eral centromedullary nailing, and replacement of the
excised segment of bone by cemented spacer.
Interestingly, histological study of the specimen
showed pathologic complete response of the tumor
(Figure 4), suggesting an important antitumor activity of
API combination in FS of bone.
Three post-operative courses of API were pro-
grammed; however, only 2 cycles of chemotherapy were
administrated, and the treatment was discontinued
because of serious adverse event (medullar aplasia that
was successfully managed).
Conclusion
Although it is not possible to make a legitimate conclu-
sion with a single presentation, this rare case of locally
advanced FS of bone highlights the role of adriamycin-
cisplatin-ifosfamid neo-adjuvant chemotherapy to
achieve limb-sparing surgery and to avoid amputation.
The promising results of API regimen in this case sug-
gest the role of chemotherapy in the management of FS
of bone.
More studies are needed to confirm the efficacy and
safety of this regimen in FS of bone and to determine
the optimal treatment plan that will improve the out-
come of these patients.
Figure 3 Sagittal T1 - weighted MR image after 3 cycles of
chemotherapy shows partial decrease in tumor volume.
Figure 4 HESX4 - Complete pathologic response after 3 cycles
of chemotherapy.
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